ClinicalTrials.gov record
Active, not recruiting Phase 3 Interventional

Escitalopram for Agitation in Alzheimer's Disease

ClinicalTrials.gov ID: NCT03108846

Public ClinicalTrials.gov record NCT03108846. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 7, 2026, 9:04 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Study identification

NCT ID
NCT03108846
Recruitment status
Active, not recruiting
Study type
Interventional
Phase
Phase 3
Lead sponsor
JHSPH Center for Clinical Trials
Other
Enrollment
187 participants

Conditions and interventions

Conditions

Interventions

  • Escitalopram Drug
  • Placebo Drug

Drug

Eligibility (public fields only)

Age range
18 Years to 109 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jan 2, 2018
Primary completion
Apr 4, 2024
Completion
Apr 30, 2025
Last update posted
Jan 30, 2025

2018 – 2025

United States locations

U.S. sites
22
U.S. states
15
U.S. cities
19
Facility City State ZIP Site status
Banner Sun Health Research Institute Sun City Arizona 85351
Biomedical Research Foundation Little Rock Arkansas 72205
University of Arkansas for Medical Sciences Little Rock Arkansas 72205
University of California Los Angeles/VA Greater Los Angeles Healthcare System Los Angeles California 90073
University of Southern California Keck School of Medicine Memory and Aging Center Los Angeles California 90089
Miami Jewish Health Systems Miami Florida 33137
Kansas School of Medicine-Wichita Center for Clinical Research Wichita Kansas 67214
Maryland VA Health Care System Baltimore Maryland 21202
Johns Hopkins University School of Medicine, Bayview Medical Center Baltimore Maryland 21224
Alzheimer Disease Center Quincy Massachusetts 02169
Hackensack Meridian Health Hackensack New Jersey 07601
Columbia University New York New York 10032
University of Rochester Medical Center Rochester New York 14620
Ohio State University Columbus Ohio 43221
Abington Neurological Associates, Ltd Abington Pennsylvania 19001
Alzheimer Disease Research Center; University of Pittsburgh Pittsburgh Pennsylvania 15213
Roper St. Francis Healthcare Charleston South Carolina 29401
Baylor AT&T Memory Center Dallas Texas 75231
UT Health San Antonio San Antonio Texas 78229
University of Virginia Adult Neurology Charlottesville Virginia 22903
Eastern Virginia Medical School Norfolk Virginia 23510
Northwest Clinical Research Center Bellevue Washington 98007

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 7 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT03108846, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jan 30, 2025 · Synced May 7, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT03108846 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →